Show simple item record

dc.contributor.authorCormie, Prue
dc.contributor.authorChambers, Suzanne K
dc.contributor.authorNewton, Robert U
dc.contributor.authorGardiner, Robert A
dc.contributor.authorSpry, Nigel
dc.contributor.authorTaaffe, Dennis R
dc.contributor.authorJoseph, David
dc.contributor.authorHamid, M Akhlil
dc.contributor.authorChong, Peter
dc.contributor.authorHughes, David
dc.contributor.authorHamilton, Kyra
dc.contributor.authorGalvao, Daniel A
dc.date.accessioned2017-05-03T14:37:24Z
dc.date.available2017-05-03T14:37:24Z
dc.date.issued2014
dc.date.modified2014-08-19T04:39:21Z
dc.identifier.issn1471-2407
dc.identifier.doi10.1186/1471-2407-14-199
dc.identifier.urihttp://hdl.handle.net/10072/62448
dc.description.abstractBackground: Despite being a critical survivorship care issue, there is a clear gap in current knowledge of the optimal treatment of sexual dysfunction in men with prostate cancer. There is sound theoretical rationale and emerging evidence that exercise may be an innovative therapy to counteract sexual dysfunction in men with prostate cancer. Furthermore, despite the multidimensional aetiology of sexual dysfunction, there is a paucity of research investigating the efficacy of integrated treatment models. Therefore, the purpose of this study is to: 1) examine the efficacy of exercise as a therapy to aid in the management of sexual dysfunction in men with prostate cancer; 2) determine if combining exercise and brief psychosexual intervention results in more pronounced improvements in sexual health; and 3) assess if any benefit of exercise and psychosexual intervention on sexual dysfunction is sustained long term. Methods/Design: A three-arm, multi-site randomised controlled trial involving 240 prostate cancer survivors will be implemented. Participants will be randomised to: 1) 'Exercise' intervention; 2) 'Exercise + Psychosexual' intervention; or 3) 'Usual Care'. The Exercise group will receive a 6-month, group based, supervised resistance and aerobic exercise intervention. The Exercise + Psychosexual group will receive the same exercise intervention plus a brief psychosexual self-management intervention that addresses psychological and sexual well-being. The Usual Care group will maintain standard care for 6 months. Measurements for primary and secondary endpoints will take place at baseline, 6 months (post-intervention) and 1 year follow-up. The primary endpoint is sexual health and secondary endpoints include key factors associated with sexual health in men with prostate cancer. Discussion: Sexual dysfunction is one of the most prevalent and distressing consequences of prostate cancer. Despite this, very little is known about the management of sexual dysfunction and current health care services do not adequately meet sexual health needs of survivors. This project will examine the potential role of exercise in the management of sexual dysfunction and evaluate a potential best-practice management approach by integrating pharmacological, physiological and psychological treatment modalities to address the complex and multifaceted aetiology of sexual dysfunction following cancer.
dc.description.peerreviewedYes
dc.description.publicationstatusYes
dc.format.extent450954 bytes
dc.format.mimetypeapplication/pdf
dc.languageEnglish
dc.publisherBioMed Central
dc.publisher.placeUnited Kingdom
dc.relation.ispartofstudentpublicationN
dc.relation.ispartofpagefrom199-1
dc.relation.ispartofpageto199-9
dc.relation.ispartofjournalBMC Cancer
dc.relation.ispartofvolume14
dc.rights.retentionY
dc.subject.fieldofresearchExercise physiology
dc.subject.fieldofresearchOncology and carcinogenesis
dc.subject.fieldofresearchcode420702
dc.subject.fieldofresearchcode3211
dc.titleImproving sexual health in men with prostate cancer: randomised controlled trial of exercise and psychosexual therapies
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
dcterms.licensehttp://creativecommons.org/licenses/by/2.0
gro.description.notepublicPage numbers are not for citation purposes. Instead, this article has the unique article number of 199.
gro.rights.copyright© 2014 Cormie et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
gro.hasfulltextFull Text
gro.griffith.authorChambers, Suzanne K.
gro.griffith.authorHamilton, Kyra


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record